Detalhe da pesquisa
1.
Brain metastasis as the first and only metastatic relapse site portends worse survival in patients with advanced HER2 + breast cancer.
Breast Cancer Res Treat
; 197(2): 425-434, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36403183
2.
Available Systemic Treatments and Emerging Therapies for Breast Cancer Brain Metastases.
Curr Treat Options Oncol
; 24(6): 611-627, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071254
3.
Systemic management of brain metastases in HER2+ breast cancer in 2022.
Clin Adv Hematol Oncol
; 20(5): 325-336, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579591
4.
Survival Outcomes Among Patients with Metastatic Breast Cancer: Review of 47,000 Patients.
Ann Surg Oncol
; 28(12): 7441-7449, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34050430
5.
Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.
Breast Cancer Res Treat
; 176(2): 321-328, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31016641
6.
Unique genomic alterations in the circulating tumor DNA of patients with solid tumors brain metastases.
Neurooncol Adv
; 6(1): vdae052, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38680992
7.
Axillary nodal disease burden is not associated with an elevated 21-gene recurrence score in post-menopausal women presenting with a clinically negative axilla.
Am J Surg
; 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38350748
8.
Phase II DORA Study of Olaparib with or without Durvalumab as a Chemotherapy-Free Maintenance Strategy in Platinum-Pretreated Advanced Triple-Negative Breast Cancer.
Clin Cancer Res
; 30(7): 1240-1247, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38236575
9.
Tumor Mutational Burden in Breast Cancer: Current Evidence, Challenges, and Opportunities.
Cancers (Basel)
; 15(15)2023 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37568813
10.
Filling the Gap after CDK4/6 Inhibitors: Novel Endocrine and Biologic Treatment Options for Metastatic Hormone Receptor Positive Breast Cancer.
Cancers (Basel)
; 15(7)2023 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046675
11.
Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer.
Front Oncol
; 13: 1235902, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37637072
12.
Durable responses in patients with HER2+ breast cancer and leptomeningeal metastases treated with trastuzumab deruxtecan.
NPJ Breast Cancer
; 9(1): 19, 2023 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997605
13.
Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases.
Clin Cancer Res
; 29(1): 174-182, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36074155
14.
Efficacy, safety and toxicity management of adjuvant abemaciclib in early stage HR+/HER2- high-risk breast cancer.
Expert Rev Anticancer Ther
; 22(8): 805-814, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737886
15.
Metastatic breast cancer: Who benefits from surgery?
Am J Surg
; 223(1): 81-93, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34325907
16.
Utilization of neoadjuvant chemotherapy in high-risk, node-negative early breast cancer.
Cancer Med
; 11(4): 1099-1108, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34989142
17.
APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine Therapy.
JCO Precis Oncol
; 6: e2200149, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315915
18.
Advances in the management of breast cancer brain metastases.
Neurooncol Adv
; 3(Suppl 5): v63-v74, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34859234
19.
Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data.
Clin Breast Cancer
; 21(4): e340-e361, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33446413
20.
The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part I: Early-Stage Disease.
Drugs Aging
; 37(5): 331-348, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32100240